GB Patent

GB0418046D0 — Eantioselective process

Assigned to Prosidion Ltd · Expires 2004-09-15 · 22y expired

What this patent protects

Patent listed against Tradjenta.

Drugs covered by this patent

Tradjenta (LINAGLIPTIN) · Boehringer Ingelheim

Patent Metadata

Patent number: GB0418046D0
Jurisdiction: GB
Classification: —
Expires: 2004-09-15
Drug substance claim: No
Drug product claim: No
Assignee: Prosidion Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.